• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
Y20170001727 氯化钇-90无菌溶液 Other Other Import Drug Application 2018-04-20 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd view
JXHL1600004 硫酸长春新碱脂质体注射液 vincristine sulfate Injection Chemical Drugs Import Drug Application 2016-01-20 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd In Review 2016-01-19 view
JXSL1700038 注射用替伊莫单抗 ibritumomab tiuxetan Lyophilized Biological Products Import Drug Application 2017-07-11 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd In Review 2017-07-08 view
JXHL1600141 注射用盐酸美法仑 MELPHALAN HYDROCHLORIDE Lyophilized Chemical Drugs(5.1) Import Drug Application 2016-12-09 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd Certificate Issued 2018-12-03 view
JYHB1900419 注射用盐酸美法仑 MELPHALAN HYDROCHLORIDE Lyophilized Chemical Drugs(5.1) Supplementary Application 2019-04-04 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd Filed 2019-04-11 view
JYHB1901405 注射用盐酸美法仑 MELPHALAN HYDROCHLORIDE Lyophilized Chemical Drugs(5.1) Supplementary Application 2019-11-29 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd Certificate Issued 2019-12-26 view
JYHB1900421 注射用盐酸美法仑 MELPHALAN HYDROCHLORIDE Lyophilized Chemical Drugs(5.1) Supplementary Application 2019-04-15 英创远达(北京)生物医药科技有限公司 CASI(Beijing)Pharmaceuticals Technology Co Ltd Certificate Issued 2020-04-09 view